Transhepatic endoprosthesis and surgical anastomosis in the palliative treatment of bile duct obstructions.
Ninety-six patients with non-resectable malignant tumours occluding the bile duct were treated either with a transhepatic endoprosthesis (n = 60) or a surgical biliointestinal anastomosis (n = 36). The mean survival time for patients treated with a transhepatic endoprosthesis was 5.8 months, as compared with 8,1 months for patients treated surgically. The mortality rates in the first 30 days were 18% and 17% for patients treated anastomosis, respectively. We consider that this militates in favour of an endoprosthesis rather than surgery.
Skjennald
A
A
Department of Radiology, Ullevaal University Hospital, Oslo.
Heldaas
J
J
Henjum
A
A
Kåresen
R
R
D000368:Aged; D002768:Choledochostomy; D002779:Cholestasis / Q000209:etiology / Q000601:surgery*; D004067:Digestive System Neoplasms / Q000150:complications; D004322:Drainage / Q000295:instrumentation*; D005260:Female; D005704:Gallbladder / Q000601:surgery; D006801:Humans; D007583:Jejunum / Q000601:surgery; D008297:Male; D010166:Palliative Care / Q000379:methods*